Search research articles
Contact Us
Filters
Showing results (231-240 of 254) with videos related to
Page
of 26
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 21, 2026
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old
Patricia Winokur, Oyeniyi Diya, David Fitz-Patrick, et al.
The New England Journal of Medicine
|
July 19, 2023
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus
Shabir A Madhi, Annaliesa S Anderson, Judith Absalon, et al.
Mbio
|
March 15, 2018
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine
Lisa K McNeil, Robert G K Donald, Alexey Gribenko, et al.
The New England Journal of Medicine
|
May 27, 2021
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Robert W Frenck, Nicola P Klein, Nicholas Kitchin, et al.
The Journal of Infection
|
February 25, 2015
Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy
Catherine A Jeppesen, Matthew D Snape, Hannah Robinson, et al.
The New England Journal of Medicine
|
December 10, 2020
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, et al.
The Journal of Infectious Diseases
|
June 19, 2009
Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis
Ellen Murphy, Lubomira Andrew, Kwok-Leung Lee, et al.
The New England Journal of Medicine
|
January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years
Patricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
The New England Journal of Medicine
|
October 16, 2024
RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons
Edward E Walsh, Gonzalo Pérez Marc, Ann R Falsey, et al.
The New England Journal of Medicine
|
September 15, 2021
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 254) with videos related to
Sort By:
Page
of 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 21, 2026
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old
Patricia Winokur, Oyeniyi Diya, David Fitz-Patrick, et al.
The New England Journal of Medicine
|
July 19, 2023
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus
Shabir A Madhi, Annaliesa S Anderson, Judith Absalon, et al.
Mbio
|
March 15, 2018
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine
Lisa K McNeil, Robert G K Donald, Alexey Gribenko, et al.
The New England Journal of Medicine
|
May 27, 2021
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Robert W Frenck, Nicola P Klein, Nicholas Kitchin, et al.
The Journal of Infection
|
February 25, 2015
Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy
Catherine A Jeppesen, Matthew D Snape, Hannah Robinson, et al.
The New England Journal of Medicine
|
December 10, 2020
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, et al.
The Journal of Infectious Diseases
|
June 19, 2009
Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis
Ellen Murphy, Lubomira Andrew, Kwok-Leung Lee, et al.
The New England Journal of Medicine
|
January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years
Patricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
The New England Journal of Medicine
|
October 16, 2024
RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons
Edward E Walsh, Gonzalo Pérez Marc, Ann R Falsey, et al.
The New England Journal of Medicine
|
September 15, 2021
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, et al.
Page
of 26